Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

The market is segmented By Treatment (Devices (Catheters, Stents, Other Devices), and Drugs), End-user and Geography.

Home right-chevron-icon Industry Reports right-chevron-icon Healthcare right-chevron-icon Therapeutics right-chevron-icon Uropathy Treatment Market

Uropathy Treatment Market Size

obstructive uropathy treatment 1
Study Period: 2018 - 2028
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.2 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order
setting-icon

Need a report that reflects how COVID-19 has impacted this market and it's growth?

Uropathy Treatment Market Analysis

The Uropathy Treatment Market is expected to register a CAGR of 4.2% during the forecast period. Uropathy/obstructive uropathy may occur due to kidney stones, bladder stones, blood clots, uterine cancer, colon cancer, cervical cancer, and problems with the nerves that supply the bladder. Treatment available for management of uropathy includes stents, catheters and drugs.

According to a study published in Advances in Urology, Kidney stone disease is an increasing urological disorder of human health which is affecting about 15% of the world population and it affects all age groups but occurs more frequently in men than in women within the age of 20–49 years. Moreover, during lifetime, approximately 7% of women and 13% of men will develop a kidney stone.

Increasing prevalence of kidney stone, urological disorders and rising incidence of cancer and technological advancement in catheters and stents are the key driving factors in uropathy treatment market.

Uropathy Treatment Industry Segmentation

As per the scope of the report, Uropathy is a disease of the urinary or urogenital organs that may result in the urinary related problems. Urinary system related problems include conditions such as kidney failure, urinary tract infections, kidney stones, prostate enlargement, and bladder control problems. Uropathy Treatment Market is segmented By Treatment type, End-user and Geography.

By Treatment
Devices
Catheters
Stents
Other Devices
Drugs
End-user
Hospitals and Clinics
Ambulatory Surgical Centre
Other End-users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Uropathy Treatment Market Trends

This section covers the major market trends shaping the Uropathy Treatment Market according to our research experts:

Stents Segment is Expected to Hold a Major Market Share in the Uropathy Treatment Market

  • A stent is a thin tube used to prevent or treat a blockage that prevents the flow of urine from the kidneys. The length of the stents used in adult patients varies between 24 and 30 cm. Additionally, stents come in differing gauges or diameters, to fit different size ureters.
  • According to the American Academy of Family Physicians (AAFP), Kidney stones are a common disorder, with an annual incidence of eight cases per 1,000 adults. Moreover, around 13% of men and 7% of women develop a kidney stone in their lifetime and the overall incidence of urinary retention is 4.5 to 6.8 per 1,000 men, per year, in the United States. Moreover, the stent is used when there is a blockage in the ureter (in case of kidney stones) and allows urine to drain around the blockage and also decrease the pain associated with the blockage (i.e. kidney stone). In some cases, infection associated with the kidney stone stents helps to drain the infected urine. 
  • Stents segment holds a significant market share in the uropathy treatment market and is anticipated to show a similar trend over the forecast period due to the availability of specific product types according to the requirements.
  • Increasing prevalence of urological disorders and technological advancement in the material used for stents are the key driving factors in the stents segment.
Obstructive Uropathy Treatment key trend 1.png

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global uropathy treatment market due to increasing prevalence of kidney stones in this region. According to a study published in the Clinical Journal of the American Society of Nephrology, in the United States, 1 in 11 individuals will experience a urinary stone in their lifetime. In addition, the frequency of urinary stone disease (USD) in children is increasing (4%-6%) yearly, particularly among adolescents. Furthermore, the increase in technological advancements and new product launches, and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Obstructive Uropathy Treatment Market 2

Uropathy Treatment Industry Overview

The Uropathy Treatment Market is fragmented competitive and consists of several major players. Some of the leading companies operating in the market include Boston Scientific Corporation, Cook Medical, Bayer AG, Sanofi, B. Braun Melsungen AG, C. R. Bard, Inc, Olympus Corporation, Teleflex Incorporated, Merit Medical Systems, Inc and Argon Medical Devices, Inc.

Uropathy Treatment Market Leaders

  1. Boston Scientific Corporation

  2. B. Braun Melsungen AG

  3. Cook Medical

  4. Bayer AG

  5. Sanofi

*Disclaimer: Major Players sorted in no particular order

CP Uropathy.png

Uropathy Treatment Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Urological Disorders

      2. 4.2.2 Technological Advancement in the Material Used for Catheters and Stents

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Infection due to Stents and Catheters

      2. 4.3.2 Discomfort and Pain due to Stents and Catheters

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Treatment

      1. 5.1.1 Devices

        1. 5.1.1.1 Catheters

        2. 5.1.1.2 Stents

        3. 5.1.1.3 Other Devices

      2. 5.1.2 Drugs

    2. 5.2 End-user

      1. 5.2.1 Hospitals and Clinics

      2. 5.2.2 Ambulatory Surgical Centre

      3. 5.2.3 Other End-users

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Boston Scientific Corporation

      2. 6.1.2 Cook Medical

      3. 6.1.3 Bayer AG

      4. 6.1.4 Sanofi

      5. 6.1.5 B. Braun Melsungen AG

      6. 6.1.6 C. R. Bard, Inc

      7. 6.1.7 Olympus Corporation

      8. 6.1.8 Teleflex Incorporated

      9. 6.1.9 Merit Medical Systems, Inc

      10. 6.1.10 Argon Medical Devices, Inc

      2. *List Not Exhaustive

  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You can also purchase parts of this report. Do you want to check out a section wise price list?

Uropathy Treatment Market Research FAQs

The Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) is studied from 2018 - 2028.

The Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) is growing at a CAGR of 4.2% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2018 - 2028.

North America holds highest share in 2021.

Boston Scientific Corporation, B. Braun Melsungen AG, Cook Medical, Bayer AG, Sanofi are the major companies operating in Uropathy Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028).

Uropathy Treatment Industry Report

Statistics for the 2023 Uropathy Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Uropathy Treatment analysis includes a market forecast outlook to 2028 and historical overview. Get a sample of this industry analysis as a free report PDF download.

close-icon
80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!